VulnerabilityAnalyzed
CVE-2026-44115
OpenClaw before 2026.4.22 contains an exec allowlist analysis vulnerability allowing shell expansion hiding in unquoted heredoc bodies.
HIGH 8.7EPSS 0.36%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.36%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
OpenClaw before 2026.4.22 contains an exec allowlist analysis vulnerability allowing shell expansion hiding in unquoted heredoc bodies. Attackers can bypass allowlist validation by embedding shell expansion tokens in heredoc bodies to execute unapproved commands at runtime.
- CVSS 4.0
- 8.7 HIGHCVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
- EPSS
- 0.36% probability · 30th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-184
- Affected
- openclaw/openclaw
- Source
- disclosure@vulncheck.com
References
- https://github.com/openclaw/openclaw/commit/b2e8b7d4bb2f22eaa16f5c4b07547774e90b65a5Patch
- https://github.com/openclaw/openclaw/security/advisories/GHSA-x3h8-jrgh-p8jxMitigation, Vendor Advisory
- https://www.vulncheck.com/advisories/openclaw-shell-expansion-bypass-in-unquoted-heredocs-via-exec-allowlistThird Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.